Evidence map›Paper›PMID 28057753›Full record

ArticleThe Journal of biological chemistry2017

A Novel Kleefstra Syndrome-associated Variant That Affects the Conserved TPL

Patrick R Blackburn, Alexander Tischer, Michael T Zimmermann, Jennifer L Kemppainen, Sujatha Sastry, Amy E Knight Johnson, Margot A Cousin, Nicole J Boczek, Gavin Oliver, Vinod K Misra and 5 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Epigenetics and Congenital Heart Diseases.Journal of cardiovascular development and disease · 2022
    Review
  12. Article
  13. Impact of integrated translational research on clinical exome sequencing.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Patrick R BlackburnFrom the Center for Individualized Medicine and.
Alexander Tischerthe Division of Hematology, Departments of Internal Medicine and Biochemistry and Molecular Biology.
Michael T Zimmermannthe Department of Health Science Research, Division of Biomedical Statistics and Informatics.
Jennifer L Kemppainenthe Department of Clinical Genomics.
Sujatha Sastrythe Department of Pediatrics, Division of Genetics and Metabolic Disorders, Wayne State University School of Medicine, Detroit, Michigan 48201, and.
Amy E Knight Johnsonthe Department of Human Genetics, University of Chicago, Chicago, Illinois 60637.
Margot A Cousinthe Center for Individualized Medicine.
Nicole J Boczekthe Center for Individualized Medicine.
Gavin Oliverthe Center for Individualized Medicine.
Vinod K Misrathe Department of Pediatrics, Division of Genetics and Metabolic Disorders, Wayne State University School of Medicine, Detroit, Michigan 48201, and.
Ralitza H Gavrilovathe Department of Clinical Genomics.
Gwen Lomberkthe Laboratory of Epigenetics and Chromatin Dynamics, Epigenomics Translational Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota 55905.
Matthew Autonthe Division of Hematology, Departments of Internal Medicine and Biochemistry and Molecular Biology.
Raul Urrutiathe Laboratory of Epigenetics and Chromatin Dynamics, Epigenomics Translational Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota 55905, urrutia.raul@mayo.edu.
Eric W Kleethe Department of Clinical Genomics, klee.eric@mayo.edu.
Mayo Clinic · USMayo Clinic in Florida · USWayne State University · USUniversity of Chicago · US

Funding

Tissue CoreP50CA102701 · NCI · MAYO CLINIC ROCHESTER · PI PETERSEN, GLORIA M. · 2004 to 2018
$32.7M
ZINC FINGER GENES AND PANCREATIC CELL GROWTHR01DK052913 · NIDDK · MEDICAL COLLEGE OF WISCONSIN · PI LOMBERK, GWEN, URRUTIA, RAUL A. · 1998 to 2023
$7.0M
Novel Experimental Therapeutics for Pancreatic CancerR01CA178627 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI LOMBERK, GWEN · 2014 to 2018
$1.6M
NCI NIH HHS P50 CA102701NCI NIH HHS R01 CA178627NIDDK NIH HHS R01 DK052913
6 · The paper itself

Abstract

Kleefstra syndrome (KS) (Mendelian Inheritance in Man (MIM) no. 610253), also known as 9q34 deletion syndrome, is an autosomal dominant disorder caused by haploinsufficiency of euchromatic histone methyltransferase-1 (

Indexed as

Ankyrin RepeatAmino Acid MotifsAutism Spectrum DisorderChild, PreschoolChromosome DeletionChromosomes, Human, Pair 9Craniofacial AbnormalitiesFemaleGenetic VariationGenomicsHeart Defects, CongenitalHistone-Lysine N-MethyltransferaseHumansIntellectual DisabilityMolecular Dynamics SimulationMutation, MissenseEHMT1 protein, humanHistone-Lysine N-Methyltransferase9q34 deletion syndromeDNA sequencingEHMT1functional genomicsfunctional validationgenetic diseaseGLPKleefstra syndromemolecular dynamicsmolecular modeling

Identifiers

PMID28057753
PMCPMC5339767
OpenAlexW2567988948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.